NASDAQ: INDP - Indaptus Therapeutics, Inc.

六个月盈利: -50.94%
部门: Healthcare

促销时间表 Indaptus Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc.

更多详情
is headquartered in New York, New York.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

EBITDA -0.0341
EV/EBITDA -0.2592
IPO date 2015-08-04
ISIN US45339J1051
Industry Biotechnology
P/BV 1.46
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://indaptusrx.com
Цена ао 2.8
Число акций ао 0.0084 млрд
每日价格变化: -0.8475% (1.18)
每周价格变化: +10.38% (1.06)
每月价格变化: -19.31% (1.45)
3个月内价格变化: -47.06% (2.21)
六个月内的价格变化: -50.94% (2.385)
每年价格变化: -55.34% (2.62)
3年内价格变化: -87.65% (9.47)
5年内价格变化: +62.55% (0.7198)
年初以来价格变化: -53.01% (2.49)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 1.32 9
P/E 0 0
EV/EBITDA -0.1694 0
全部的: 3.63

效率

姓名 意义 年级
ROA, % -103.35 0
ROE, % -127.71 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0107 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % -51.97 0
盈利能力 EPS, % -98.37 0
全部的: 0
更多详情

机构 体积 分享, %
Vanguard Group Inc 256265 3
Investment House, LLC 102437 1.2
Geode Capital Management, LLC 54767 0.64
Strategy Asset Managers Llc 45336 0.53
Pine Valley Investments Ltd Liability Co 44240 0.52
Renaissance Technologies, LLC 29400 0.34
Vivaldi Capital Management Lp 24000 0.28
State Street Corporation 19473 0.23
Citadel Advisors Llc 16518 0.19
Tower Research Capital LLC (TRC) 4696 0.05



导师 职称 支付 出生年份
Mr. Jeffrey A. Meckler CEO & Director 867.03k 1967 (57 年)
Mr. Walt Addison Linscott Esq. Chief Operating Officer 716.35k 1961 (63 年)
Dr. Michael J. Newman Ph.D. Founder, Chief Scientific Officer & Director 659.99k 1956 (68 年)
Mr. Nir Sassi CFO, Secretary & Treasurer 378.47k 1976 (48 年)
Dr. Roger J. Waltzman M.B.A., M.D. Chief Medical Officer N/A 1968 (56 年)

地址: United States, New York. NY, Three Columbus Circle - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://indaptusrx.com